Empire Financial Management Company’s BioCryst Pharmaceuticals BCRX Stock Holding History

Empire Financial Management Company’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$780K	Buy
2025 Q1	–	Sell
2024 Q4	$263K	Sell
2024 Q3	$448K	Hold
2024 Q2	$365K	Sell
2024 Q1	$401K	Buy
2023 Q4	$440K	Buy
2023 Q3	$336K	Buy
2023 Q2	$299K	Buy
2023 Q1	$250K	Buy